AWA
OM icon

Authentikos Wealth Advisory’s Outset Medical OM Stock Holding History

Authentikos Wealth Advisory’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3
Closed -$490 – 414
2023
Q3 		$490 Buy
+3
New +$708 ﹤0.01% 570

Other funds holding OM

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Authentikos Wealth Advisory's OM Position: Q4 2023 in Review

Authentikos Wealth Advisory sold out of Outset Medical (OM) in Q4 2023, closing a stake of 3 shares — an estimated $490 sold.

Authentikos Wealth Advisory first reported a position in OM in Q3 2023 and held it in 1 quarter. The position peaked at $490 in Q3 2023. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • Authentikos Wealth Advisory reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • Authentikos Wealth Advisory sold 3 Outset Medical shares in Q4 2023, an estimated $490.
  • Authentikos Wealth Advisory first reported a position in Outset Medical in Q3 2023 and held it in 1 quarter.
  • Authentikos Wealth Advisory's Outset Medical position peaked at $490 in Q3 2023.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Authentikos Wealth Advisory's 13F filing for Q4 2023, filed 30 Jan 2024.